NCT01545505

Brief Summary

Relapse of post-traumatic stress disorder (PTSD) remains challenging. In addition, factors predicting PTSD relapse are still unknown. The aim of this study is to examine whether clinical and neuropsychological changes (e.g., attentional bias toward aversive cues) that characterized PTSD can be observed in people with past PTSD (children and their families) and whether these persistent changes are predictive of PTSD relapse.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2011

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 6, 2012

Completed
7 months until next milestone

Study Start

First participant enrolled

October 1, 2012

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

February 21, 2013

Status Verified

February 1, 2013

Enrollment Period

1 year

First QC Date

December 8, 2011

Last Update Submit

February 20, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Attentional score

    Go-No/Go and visual search tests

    baseline at the first visit (T0), at 6 months, at 9 months

Secondary Outcomes (1)

  • memory (Grober and Buschke)

    baseline at the first visit (T0), at 6 months, at 9 months

Study Arms (2)

In remission phase of PTSD

OTHER

Patients having suffered from PTSD in the past and in remission od PTSD and their parents

Behavioral: Neuropsychological assessment

Activ PTSD

OTHER

patients suffering from PTSD (Post-traumatic Stress Disorder) and their parents

Behavioral: Neuropsychological assessment

Interventions

A clinical evaluation with Impact of Events Scale-Revised, Child Post-Traumatic Stress Reaction Index, State-Trait Anxiety Inventory for Children, Children Depression Inventory and Emotion, activity and sociability. A neuropsychological assessment with a emotional Go-No/Go, a visual search task, the Trail Making Test, 3 items of the WISC III ( and the Grober and Buschke Test.

Activ PTSDIn remission phase of PTSD

Eligibility Criteria

Age9 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Children (9/18 years)
  • Patients who have lived a traumatic event (physical assault and road accident) and who have a PTSD.
  • French speaker.
  • Participants must sign the informed consent and they must be affiliated to the social insurance.

You may not qualify if:

  • Children who have a neurological pathology.
  • Children who have brain damage or brain-injured

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

CHU de NICE

Nice, 06000, France

RECRUITING

Fondation Lenval

Nice, 06000, France

RECRUITING

CHU de TOULOUSE

Toulouse, 31059, France

NOT YET RECRUITING

CHU de TOURS

Tours, 37044, France

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Neuropsychological Tests

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and Activities

Study Officials

  • Michel BENOIT, M.D.,PhD

    Psychiatrie, Hôpital Pasteur, CHU de NICE

    PRINCIPAL INVESTIGATOR
  • Wissam EL HAGE, M.D, PhD

    Psychiatrie, CHU de TOURS

    PRINCIPAL INVESTIGATOR
  • Frédérique JOVER, M.D.

    CAP, Hôpital St ROCH, CHU de NICE

    PRINCIPAL INVESTIGATOR
  • Florence ASKENAZY, M.D.

    Fondation Lenval, NICE

    PRINCIPAL INVESTIGATOR
  • Philippe BIRMES, M.D.

    Psychiatrie, CHU de TOULOUSE

    PRINCIPAL INVESTIGATOR
  • Virginie BUISSE, M.D.

    CAP, Hôpital St Roch, CHU de NICE

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michel BENOIT, PhD

CONTACT

morgane gindt

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2011

First Posted

March 6, 2012

Study Start

October 1, 2012

Primary Completion

October 1, 2013

Study Completion

July 1, 2014

Last Updated

February 21, 2013

Record last verified: 2013-02

Locations